Suppr超能文献

皮肤带状疱疹感染进展过程中肥大细胞蛋白酶和蛋白酶抑制剂的变化。

Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.

作者信息

Kaminska R, Harvima I T, Naukkarinen A, Nilsson G, Horsmanheimo M

机构信息

Department of Dermatology, Kuopio University Hospital, Finland.

出版信息

J Pathol. 1996 Dec;180(4):434-40. doi: 10.1002/(SICI)1096-9896(199612)180:4<434::AID-PATH682>3.0.CO;2-B.

Abstract

The possible involvement of mast cell proteases in the cutaneous inflammation of herpes zoster was studied histochemically in ten patients. Mast cell tryptase and chymase bioactivities were demonstrated enzyme-histochemically. The localization of protease inhibitors as well as tryptase and chymase proteins in mast cells was established using a sequential double-staining method which first demonstrated bioactive tryptase or chymase, followed by immunohistochemical identification of these antigens. Biopsies were taken from involved vesicular and erythematous skin, as well as from normal healthy-looking skin. Tryptase-bioactive mast cells were significantly lower in number in the upper, but not in the deeper dermis of vesicular skin (68 +/- 37 cells/mm2, mean +/- SD) when compared with either healthy-looking (97 +/- 38) or erythematous skin (105 +/- 36) (t-test, P < 0.005). In contrast, chymase-bioactive mast cells were significantly reduced in number both in erythematous skin (44 +/- 20, P < 0.02) and even more so in vesicular skin (26 +/- 20, P < 0.0005) when compared with healthy-looking skin (64 +/- 27). The percentage of alpha 1-antitrypsin -immunoreactive and alpha 1-antichymotrypsin-immunoreactive mast cells in the upper dermis increased steadily from the values in healthy-looking skin (37.9 +/- 18.8 and 82.5 +/- 21.6 per cent) to those in erythematous (64.4 +/- 16.4 and 93.5 +/- 7.9 per cent) and vesicular skin (75.2 +/- 10.2 and 96.4 +/- 4 per cent). A novel finding was that cells showing tryptase immunoreactivity but no enzyme activity were found in two out of nine erythematous skin specimens and in four out of seven vesicular specimens. In healthy-looking skin, all cells with chymase immunoreactivity also displayed chymase bioactivity, but only 53.2 +/- 24.25 per cent of these mast cells in erythematous lesions and 44.4 +/- 15.9 per cent in vesicular lesions showed chymase bioactivity, suggesting inactivation of chymase by protease inhibitors. These results show prominent alterations in mast cell proteinases and protease inhibitors, indicating that these enzymes participate in the cutaneous inflammation due to herpes zoster.

摘要

采用组织化学方法对10例带状疱疹皮肤炎症中肥大细胞蛋白酶的可能作用进行了研究。通过酶组织化学方法证实了肥大细胞类胰蛋白酶和糜蛋白酶的生物活性。采用顺序双重染色法确定肥大细胞中蛋白酶抑制剂以及类胰蛋白酶和糜蛋白酶蛋白的定位,该方法首先显示生物活性类胰蛋白酶或糜蛋白酶,然后通过免疫组织化学鉴定这些抗原。从受累的水疱性和红斑性皮肤以及外观正常的健康皮肤取材进行活检。与外观正常皮肤(97±38个细胞/mm²)或红斑性皮肤(105±36个细胞/mm²)相比,水疱性皮肤浅层真皮中类胰蛋白酶生物活性肥大细胞数量显著减少(68±37个细胞/mm²,平均值±标准差)(t检验,P<0.005),但深层真皮中数量未减少。相比之下与外观正常皮肤(64±27个细胞/mm²)相比,红斑性皮肤中糜蛋白酶生物活性肥大细胞数量显著减少(44±20个细胞/mm²,P<0.02),水疱性皮肤中减少更明显(26±20个细胞/mm²,P<0.0005)。真皮上层中α1-抗胰蛋白酶免疫反应性和α1-抗糜蛋白酶免疫反应性肥大细胞的百分比从外观正常皮肤中的值(37.9±18.8%和82.5±21.6%)稳步增加到红斑性皮肤中的值(64.4±16.4%和93.5±7.9%)以及水疱性皮肤中的值(75.2±10.2%和96.4±4%)。一个新发现是,在9例红斑性皮肤标本中的2例以及7例水疱性标本中的4例中发现了显示类胰蛋白酶免疫反应性但无酶活性的细胞。在外观正常皮肤中,所有具有糜蛋白酶免疫反应性的细胞也显示出糜蛋白酶生物活性,但在红斑性病变中这些肥大细胞中只有53.2±24.25%显示出糜蛋白酶生物活性,在水疱性病变中为44.4±15.9%,这表明蛋白酶抑制剂使糜蛋白酶失活。这些结果表明肥大细胞蛋白酶和蛋白酶抑制剂有显著改变,提示这些酶参与了带状疱疹引起的皮肤炎症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验